These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28511600)

  • 21. Re-emerging Lassa fever outbreaks in Nigeria: Re-enforcing "One Health" community surveillance and emergency response practice.
    Tambo E; Adetunde OT; Olalubi OA
    Infect Dis Poverty; 2018 Apr; 7(1):37. PubMed ID: 29703243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lassa virus RNA detection from suspected cases in Nigeria, 2011-2017.
    Babalola SO; Babatunde JA; Remilekun OM; Amaobichukwu AR; Abiodun AM; Jide I; Adeshina AI; Chikwe I; Aremu OS
    Pan Afr Med J; 2019; 34():76. PubMed ID: 31819792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combating Lassa fever for sustainable development: Interplay of perceived behavioural control and current preventive practices in most endemic States in Nigeria.
    Ben-Enukora CA; Oyero OS; Oyesomi KO; Adeyeye BK
    Afr J Reprod Health; 2021 Nov; 25(s5):126-137. PubMed ID: 37585777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outbreak of lassa fever in Nigeria: measures for prevention and control.
    Mofolorunsho KC
    Pan Afr Med J; 2016; 23():210. PubMed ID: 27347299
    [No Abstract]   [Full Text] [Related]  

  • 25. [Knowledge and attitudes of community volunteers on Lassa and Ebola viral haemorrhagic fevers in the Donga Department (North Benin)].
    Attinsounon CA; Hounnankan CA; Dovonou CA; Alassani CA; Salifou S
    Pan Afr Med J; 2017; 26():229. PubMed ID: 28690743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice.
    Fisher-Hoch SP; Tomori O; Nasidi A; Perez-Oronoz GI; Fakile Y; Hutwagner L; McCormick JB
    BMJ; 1995 Sep; 311(7009):857-9. PubMed ID: 7580496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors associated with delayed presentation to healthcare facilities for Lassa fever cases, Nigeria 2019: a retrospective cohort study.
    Chandra NL; Bolt H; Dan-Nwafor C; Ipadeola O; Ilori E; Namara G; Olayinka AT; Ukponu W; Iniobong A; Amedu M; Akano A; Akabike KO; Okhuarobo U; Fagbemi S; Sampson E; Newitt S; Verlander NQ; Bausch DG; le Polain de Waroux O; Ihekweazu C
    BMC Infect Dis; 2021 Feb; 21(1):143. PubMed ID: 33541278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Engaging Market Traders in Lassa Fever Campaign: Assessment of Knowledge and Risk Behaviour.
    Tobin EA; Asogun DA; Ehidiamen G; Elugbe B; Osiemi B
    West Afr J Med; 2015; 34(2):89-93. PubMed ID: 27492545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of Ebola Virus Disease outbreak on hand washing among secondary school students in Ondo State Nigeria, October, 2014.
    Ilesanmi OS; Alele FO
    Pan Afr Med J; 2015; 22 Suppl 1(Suppl 1):24. PubMed ID: 26740852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knowledge of Secondary School Children in Edo State on Lassa Fever and its Implications for Prevention and Control.
    Tobin EA; Asogun DA; Esumeh R; Omuninu R; Ehidiamen G; Giwa R
    West Afr J Med; 2015; 34(2):101-7. PubMed ID: 27492547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiological trends of Lassa fever in Nigeria, 2018-2021.
    Dalhat MM; Olayinka A; Meremikwu MM; Dan-Nwafor C; Iniobong A; Ntoimo LF; Onoh I; Mba S; Ohonsi C; Arinze C; Esu EB; Nwafor O; Oladipupo I; Onoja M; Ilori E; Okonofua F; Ochu CL; Igumbor EU; Adetifa I
    PLoS One; 2022; 17(12):e0279467. PubMed ID: 36584167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measures to control protracted large Lassa fever outbreak in Nigeria, 1 January to 28 April 2019.
    Dan-Nwafor CC; Furuse Y; Ilori EA; Ipadeola O; Akabike KO; Ahumibe A; Ukponu W; Bakare L; Okwor TJ; Joseph G; Mba NG; Akano A; Olayinka AT; Okoli I; Okea RA; Makava F; Ugbogulu N; Oladele S; Namara G; Muwanguzi EN; Naidoo D; Mutbam SK; Okudo I; Woldetsadik SF; Lasuba CL; Ihekweazu C
    Euro Surveill; 2019 May; 24(20):. PubMed ID: 31115314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RISK PERCEPTION, KNOWLEDGE, ATTITUDE AND PRACTICES TOWARDS COVID-19 AND LASSA FEVER PREVENTION AMONG DOCTORS AND NURSES IN A TREATMENT CENTRE IN NIGERIA.
    Ilesanmi OS; Kareem AO; Afolabi AA; Kareem AJ; Ukwenya V
    Ann Ib Postgrad Med; 2021 Jun; 19(Suppl 1):S8-S14. PubMed ID: 35095363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of Lassa fever diagnosis in suspected cases reporting to health facilities in Nigeria.
    Ochu CL; Ntoimo L; Onoh I; Okonofua F; Meremikwu M; Mba S; Iniobong A; Nwafor O; Dalhat M; Ohonsi C; Arinze C; Esu E; Igumbor EU; Dan-Nwafor C; Ilori E; Adetifa I
    Sci Rep; 2023 Apr; 13(1):6545. PubMed ID: 37085507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiologic and Clinical Features of Lassa Fever Outbreak in Nigeria, January 1-May 6, 2018.
    Ilori EA; Furuse Y; Ipadeola OB; Dan-Nwafor CC; Abubakar A; Womi-Eteng OE; Ogbaini-Emovon E; Okogbenin S; Unigwe U; Ogah E; Ayodeji O; Abejegah C; Liasu AA; Musa EO; Woldetsadik SF; Lasuba CLP; Alemu W; Ihekweazu C;
    Emerg Infect Dis; 2019 Jun; 25(6):1066-1074. PubMed ID: 31107222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Descriptive epidemiology of Lassa fever in Nigeria, 2012-2017.
    Okoro OA; Bamgboye E; Dan-Nwafor C; Umeokonkwo C; Ilori E; Yashe R; Balogun M; Nguku P; Ihekweazu C
    Pan Afr Med J; 2020; 37():15. PubMed ID: 33062117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hospital-based surveillance for Lassa fever in Edo State, Nigeria, 2005-2008.
    Ehichioya DU; Asogun DA; Ehimuan J; Okokhere PO; Pahlmann M; Olschläger S; Becker-Ziaja B; Günther S; Omilabu SA
    Trop Med Int Health; 2012 Aug; 17(8):1001-4. PubMed ID: 22594713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Containing a Lassa fever epidemic in a resource-limited setting: outbreak description and lessons learned from Abakaliki, Nigeria (January-March 2012).
    Ajayi NA; Nwigwe CG; Azuogu BN; Onyire BN; Nwonwu EU; Ogbonnaya LU; Onwe FI; Ekaete T; Günther S; Ukwaja KN
    Int J Infect Dis; 2013 Nov; 17(11):e1011-6. PubMed ID: 23871405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lassa virus infection in Nigeria: clinical perspective overview.
    Idemyor V
    J Natl Med Assoc; 2010 Dec; 102(12):1243-6. PubMed ID: 21287906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Research as a pillar of Lassa fever emergency response: lessons from Nigeria.
    Olayinka AT; Nwafor CD; Akano A; Jan K; Ebhodaghe B; Elimian K; Ochu C; Okwor T; Ipadeola O; Ukponu W; Okudo I; Peter C; Ilori E; Ihekweazu C
    Pan Afr Med J; 2020; 37():179. PubMed ID: 33447334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.